Summary
In a significant market movement during December 2021, Vine Health was the subject of a vc funding. The transaction achieved a gross valuation of £4,148,171. Leading the round was David Giampaolo, Pam Garside, Talis Capital, KHP, Deepali Nangia, Playfair Capital, Faisal Mehmud, Ascension Ventures, Keith Gibbs, VOYAGERS Health-Tech Fund.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
David Giampaolo
Lead Investor / Acquirer
Pam Garside
Lead Investor / Acquirer
Talis Capital
Lead Investor / Acquirer
KHP
Lead Investor / Acquirer
Deepali Nangia
Lead Investor / Acquirer
Playfair Capital
Lead Investor / Acquirer
Faisal Mehmud
Lead Investor / Acquirer
Ascension Ventures
Lead Investor / Acquirer
Keith Gibbs
Lead Investor / Acquirer
VOYAGERS Health-Tech Fund
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Seed prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in